Capital Com MENA Securities Trading LLC is regulated by the Capital Market Authority.
Open platformOpen platform

IDEX Biometrics: IDEX partner to roll out IDEX Access biometric cards at healthcare provider in Japan

By Modular Finance

IDEX Biometrics ASA (OSE: IDEX) announces that a Japanese healthcare provider has selected IDEX Access biometric cards for a rollout to its staff, following a successful evaluation at the customer’s site.

The order has been placed with one of IDEX’s leading partners in Japan and will be delivered from the partner’s existing inventory of IDEX Access cards, marking the move from partner purchase to end-customer deployment.

IDEX
Identify yourself as a human

Contacts
Anders Storbråten, Executive Chairman, Tel: +47 416 38 582
E-mail: ir@idexbiometrics.com

About Us
IDEX Biometrics ASA (OSE: IDEX) develops and makes fingerprint biometric cards for access control, digital identity and payment. By authenticating identity through fingerprint biometrics rather than passwords, PINs or traditional credentials, IDEX enables secure and convenient access to physical and digital services. Fingerprint matching happens directly on the card, offline and without transmitting biometric data. Certified by Visa, Mastercard, FIDO2 and EAL6+, and backed by more than 250 patents and over USD 350 million invested in R&D, IDEX serves banks, enterprises and public sector organizations directly and through channel partners worldwide.

For more information, visit www.idexbiometrics.com

Attachments
IDEX partner to roll out IDEX Access biometric cards at healthcare provider in Japan

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.